231 related articles for article (PubMed ID: 15975330)
1. Off-label use of recombinant factor VIIA concentrates after cardiac surgery.
Despotis G; Avidan M; Lublin DM
Ann Thorac Surg; 2005 Jul; 80(1):3-5. PubMed ID: 15975330
[No Abstract] [Full Text] [Related]
2. Pharmacologic therapy for postoperative bleeding in children after cardiac surgery: when will the bleeding stop?
Yan Q; Chang AC
Pediatr Crit Care Med; 2004 May; 5(3):297-8. PubMed ID: 15167716
[No Abstract] [Full Text] [Related]
3. Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery.
Raivio P; Suojaranta-Ylinen R; Kuitunen AH
Ann Thorac Surg; 2005 Jul; 80(1):66-71. PubMed ID: 15975342
[TBL] [Abstract][Full Text] [Related]
4. The use of recombinant factor VIIa in a patient with Noonan syndrome and life-threatening bleeding.
Tofil NM; Winkler MK; Watts RG; Noonan J
Pediatr Crit Care Med; 2005 May; 6(3):352-4. PubMed ID: 15857538
[TBL] [Abstract][Full Text] [Related]
5. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
Filsoufi F; Castillo JG; Rahmanian PB; Scurlock C; Fischer G; Adams DH
Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
[TBL] [Abstract][Full Text] [Related]
6. Preemptive use of recombinant activated factor VII: many questions but few answers.
Samama CM
Can J Anaesth; 2006 Apr; 53(4):336-8. PubMed ID: 16575029
[No Abstract] [Full Text] [Related]
7. The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
Pychyńska-Pokorska M; Moll JJ; Krajewski W; Jarosik P
Pediatr Crit Care Med; 2004 May; 5(3):246-50. PubMed ID: 15115562
[TBL] [Abstract][Full Text] [Related]
8. Recombinant activated factor VII in cardiac surgery: single-center experience.
Singh SP; Chauhan S; Choudhury M; Malik V; Choudhary SK
Asian Cardiovasc Thorac Ann; 2014 Feb; 22(2):148-54. PubMed ID: 24585784
[TBL] [Abstract][Full Text] [Related]
9. Recombinant activated factor VII for refractory bleeding after cardiac surgery--a retrospective analysis of safety and efficacy.
von Heymann C; Redlich U; Jain U; Kastrup M; Schroeder T; Sander M; Grosse J; Ziemer S; Koscielny J; Konertz WF; Wernecke KD; Spies C
Crit Care Med; 2005 Oct; 33(10):2241-6. PubMed ID: 16215377
[TBL] [Abstract][Full Text] [Related]
10. Recombinant activated factor VII for life-threatening pulmonary hemorrhage after pediatric cardiac surgery.
Leibovitch L; Kenet G; Mazor K; Matok I; Vardi A; Barzilay Z; Paret G
Pediatr Crit Care Med; 2003 Oct; 4(4):444-6. PubMed ID: 14525639
[TBL] [Abstract][Full Text] [Related]
11. Safe use of recombinant activated factor VIIa for recalcitrant postoperative haemorrhage in cardiac surgery.
Tatoulis J; Theodore S; Meswani M; Wynne R; Hon-Yap C; Powar N
Interact Cardiovasc Thorac Surg; 2009 Sep; 9(3):459-62. PubMed ID: 19542087
[TBL] [Abstract][Full Text] [Related]
12. Change of coagulation after NovoSeven® use for bleeding during cardiac surgery.
Tomita E; Takase H; Tajima K; Suematsu Y
Asian Cardiovasc Thorac Ann; 2017 Feb; 25(2):99-104. PubMed ID: 28114794
[TBL] [Abstract][Full Text] [Related]
13. Recombinant factor VIIa use in cardiac surgery--expanding the arsenal therapy for intractable bleeding?
Kogan A; Berman M; Stein M; Vidne BA; Raanani E
J Cardiovasc Surg (Torino); 2004 Dec; 45(6):569-71. PubMed ID: 15746637
[TBL] [Abstract][Full Text] [Related]
14. Caution with the use of recombinant activated factor VII in treating postoperative hemorrhage in cardiac surgery.
Al-Ruzzeh S; Mahmoud A; Shah S; O'Regan D
Ann Thorac Surg; 2007 Jan; 83(1):355; author reply 355-6. PubMed ID: 17184710
[No Abstract] [Full Text] [Related]
15. Use of recombinant activated factor VII after axillofemoral bypass grafting.
Cheng CA; Ho AM
Anaesth Intensive Care; 2006 Jun; 34(3):375-8. PubMed ID: 16802495
[TBL] [Abstract][Full Text] [Related]
16. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
Pychyńska-Pokorska M; Pągowska-Klimek I; Krajewski W; Moll JJ
J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficiency of recombinant activated factor VII in postcardiotomy massive hemorrhage.
Lamarche Y; Demers P; Poirier NC; Robitaille D; Cartier R
Can J Cardiol; 2007 Aug; 23(10):809-13. PubMed ID: 17703260
[TBL] [Abstract][Full Text] [Related]
18. Massive pulmonary embolism after treatment with rFVIIa in a thrombocytopenic patient with acute myelogenous leukemia and intractable bleeding.
Mantzios G; Tsirigotis P; Pappa V; Spirou K; Giannopoulou V; Kaitsa I; Girkas K; Papageorgiou E; Dervenoulas J
Eur J Haematol; 2007 Feb; 78(2):173-4. PubMed ID: 17313564
[No Abstract] [Full Text] [Related]
19. Letter by Al-Ruzzeh and Navia regarding article, "Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery".
Al-Ruzzeh S; Navia JL
Circulation; 2010 Mar; 121(9):e234. PubMed ID: 20212289
[No Abstract] [Full Text] [Related]
20. Three-factor prothrombin complex concentrate and hemostasis after high-risk cardiovascular surgery.
Tanaka KA; Mazzeffi MA; Grube M; Ogawa S; Chen EP
Transfusion; 2013 Apr; 53(4):920-1. PubMed ID: 23565996
[No Abstract] [Full Text] [Related]
[Next] [New Search]